Skip to search formSkip to main contentSkip to account menu

Glurenorm

Known as: Sanofi Synthelabo brand of gliquidone 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

AntidiabeticsHypoglycemic AgentsSulfonylurea Compoundsgliquidone
Beglynor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The effect of glurenorm (gliquidone) on aorta in STZ induced diabetic rats.
1998
1998
[Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].
Renal function was examined in 66 proteinura-free patients at the age of 40-67 years having diabetes mellitus (DM) type II for 4… 
1995
1995
[The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus].
A peroral sugar-reducing preparation gliquidone (glurenorm) was tried in treatment of 66 patients with digestive diseases (peptic… 
1993
1993
[Use of glurenorm in patients with non-insulin-dependent diabetes mellitus and liver diseases].
Due to its pharmacokinetics, glurenorm (95% of the drug metabolite is withdrawn from the body with the bile) is widely used in… 
1993
1993
[Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
Glurenorm, a IInd generation sulfanylurea preparation, was used for a year as a sugar-reducing drug in 20 patients with non… 
1993
1993
[Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
Glurenorm, a IInd generation sulfanylurea preparation, was used for a year as a sugar-reducing drug in 20 patients with non… 
1993
1993
[A comparative evaluation of the effect of glurenorm and sulfonylurea preparations on the intravascular microcirculatory indices in type-II diabetes mellitus].
Analysis of the effects of glurenorm and some sulfonylurea drugs, such as maninil, minidiab, chlorpropamide, on some parameters… 
1993
1993
Comparative assessment of the effects of glurenorm and some sulfonylurea preparations on microcirculation in type II diabetes mellitus
1975
1975
[Pharmacokinetic behaviour of gliquidone (AR-DF 26), a new sulfonyl urea. Summary of the studies so far (author's transl)].
Pharmacokinetic studies of the new antidiabetic agent gliquidone, AR-DF 26, 1-cyclohexyl-3-((p-[2-(3,4-dihydro-7-methoxy-4,4… 
1975
1975
[Human pharmacokinetics and metabolism of 14C-labeled gliquidone (AR-DF 26)].
Investigations of pharmacokinetics and metabolism of 14C-labelled 1-cyclohexyl-3 (p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)